Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.

NCT07396168 is registered in ClinicalTrials.gov with The Skin Center Dermatology Group as lead sponsor.

NCT NCT07396168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07396168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study.
Lead sponsor
The Skin Center Dermatology Group
Phase
Phase 4
Overall status
Recruiting
Start date
February 1, 2026
Completion date
June 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lichen plano-pilaris